Amplifon S.p.A(AMFPF)
USD --+0.00%
Reward49Moderate
Risk48Moderate
📊75%Data
Thin 4% profit margin · 2.9% dividend yield
AMFPF
+0.0 · +0.00%
USD · OTCGREY
Amplifon S.p.A | Healthcare
Deep Value
Market Cap:2.31Bn
ℹ️
Reward Rating
49
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
48
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on AMFPF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Amplifon S.p.A?

distributes hearing solutions and the fitting of customized products that helps people to rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific.

AMFPF · Verdict

Moderate reward · moderate risk

AMFPF stands out on valuation and cash flow, but watch the growth signal.

Based on 88% data coverage

AMFPF · Verdict

What’s working & what to watch

Strengths 2

  • Valuation100/100

    P/E 11.8× · PEG 0.81

  • Cash flow77/100

    12% free-cash-flow margin

Watchouts 2

  • Growth26/100

    Rev +4.2% CAGR · earnings -20.0%

  • Balance sheet28/100

    Current ratio 0.61

Model-based scoring. For information only — not financial advice.

What is Amplifon S.p.A?

distributes hearing solutions and the fitting of customized products that helps people to rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. The company is listed on the OTCGREY in USA, operating in the Healthcare sector, with a market capitalisation of 2.31B, and a P/E ratio of 22.3x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (49)

The scoring profile indicates limited reward potential at this time, with valuation and profitability offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap2.31B
P/E Ratio22.3191
Dividend Yield2.87%
52 Week High23.85
52 Week Low9.46
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding220M
No. of Employees11,792
IndustryMedical Distribution
ExchangeOTCGREY
Beta0.984
CurrencyUSD · Reports in EUR